logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Max Healthcare Institute Ltd

Max Healthcare Institute

Large Cap•15,114 Employees•IPO 2020
Current Price
₹1083.60
-8.35 (-0.76%)Updated
NSE :MAXHEALTH
BSE :543220
Sector :Health Care Providers & Services
Today's Range
₹1056.50
₹1083.60
union icon
₹1088.40
52 Week Range
52W Low₹933.80
52W High₹1314.30
₹1083.60
union icon
Downside16.04%
Upside21.29%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹1,04,704.78 Cr
Market Cap
Total market value of company
P/E Ratio
73.78
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
10.78
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹14.53
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
8.34%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
14.90%
ROCE
Return on Capital Employed. >15% is good
Net Margin
17.43%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
76.23%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
46.01%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
31.40%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
30.40%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.32
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹96.50
Book Value
Net asset value per share
Dividend Yield
0.16%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
23.70%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •Max Healthcare exhibits robust quarterly sales growth, with a 31.40% increase in sales reaching ₹2028 crore, indicating strong market demand and operational efficiency. This positive trend suggests sustained revenue expansion.
  • •The company demonstrates healthy profitability, achieving a 30.40% increase in quarterly profit to ₹308 crore. This, coupled with a 26.40% operating profit margin, points to effective cost management.

Weaknesses

5 points
  • •Max Healthcare's high Price-to-Earnings (P/E) ratio of 96.40 is significantly above many peers, indicating the stock might be overvalued compared to its earnings, posing a potential risk for investors.
  • •The relatively low promoter holding of 23.74% as of 2025-09-01, a notable decrease from 50.64% in 2022-06-01, raises concerns about long-term investor confidence and stability.

Opportunities

0 points

    Threats

    1 points
    • •Max Healthcare faces intense competition from peers like Apollo Hospitals (P/E 71.78, ROCE 16.64) and Global Health (P/E 64.86, ROCE 19.74), which exhibit better valuation or efficiency metrics.

    Segment-wise Financial Analysis

    Financial Results

    Balance Sheet

    Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

    No Balance Sheet Data Available

    Standalone annual data is not available for this symbol.
    Try switching to Consolidated view.

    Shareholding Pattern

    Loading shareholding data...

    Company Insider Trading Activity

    No insider trading data available

    Corporate Action

    Company Announcements

    Technical Analysis & Indicators

    Standard pivot points - most widely used

    Pivot Points (CLASSIC)

    LevelPriceDistance% Change
    R4₹1159.63+₹76.03+7.02%
    R3₹1127.73+₹44.13+4.07%
    R2₹1108.07+₹24.47+2.26%
    R1₹1095.83+₹12.23+1.13%
    PIVOT₹1076.17-7.43-0.69%
    CURRENT₹1083.60--
    S1₹1000.13-₹83.47-7.70%
    S2₹1032.03-₹51.57-4.76%
    S3₹1044.27-₹39.33-3.63%
    S4₹1063.93-₹19.67-1.81%
    CPR Levels
    Support
    Resistance
    S4
    S3
    S2
    S1
    | CPR |
    BC: N/AP: N/ATC: N/A
    R1
    R2
    R3
    R4
    indicator
    LTP: N/A
    PDH: N/A
    PDL: N/A
    ● Market Sentiment

    is trading CPR, indicating

    ● CPR Width

    CPR is

    ● Opening Range

    Day's range: ~

    ● Price Position

    Trading Inside opening range

    Delivery Volume Analysis & Trading Activity

    Latest Volume
    3.47M
    (02 Mar 2026)
    +16.1% vs avg
    Delivery %
    53.2%
    (02 Mar 2026)
    -8.1% vs avg
    Avg Volume (20D)
    2.99M
    (03 Feb - 02 Mar)
    20-day average
    Avg Delivery %
    61.3%
    (03 Feb - 02 Mar)
    Trend ↑
    Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

    Peer Comparison & Industry Benchmarking

    Quick Compare

    Largest by Market Cap
    Apollo Hospitals Enterprise Ltd
    1.09L ₹ Cr
    Best Profit Growth
    Dr Agarwals Health Care Ltd
    151.00 %
    Highest Dividend Yield
    Rainbow Childrens Medicare Ltd
    0.51 %

    Peer Comparison

    Company Name
    AGARWALEYE
    Dr Agarwals Health Care Ltd
    APOLLOHOSP
    Apollo Hospitals Enterprise Ltd
    ASTERDM
    Aster DM Healthcare Ltd
    FORTIS
    Fortis Healthcare Ltd
    HCG
    Healthcare Global Enterprises Ltd
    JLHL
    Jupiter Life Line Hospitals Ltd
    JSLL
    KIMS
    Krishna Institute of Medical Sciences Ltd
    MEDANTA
    Global Health Ltd
    NH
    Narayana Hrudayalaya Ltd
    RAINBOW
    Rainbow Childrens Medicare Ltd

    About

    MAXHEALTH

    Max Healthcare Institute Ltd

    Max Healthcare Institute Limited is a major provider of medical and healthcare services in India, operating a diverse network of hospitals and medical centers across the country. Their services span a wide range of specialties, encompassing advanced cardiac care, orthopedics, oncology, renal sciences, neurosciences, and various surgical disciplines such as minimal access metabolic and bariatric surgery, obstetrics, gynecology, and general surgery. The company also offers highly specialized procedures such as liver, heart, kidney, lung, and bone marrow transplants, reflecting a commitment to comprehensive and advanced medical care.

    Beyond its core hospital services, Max Healthcare boasts a significant presence in ancillary healthcare sectors. Max@Home provides a convenient alternative for patients seeking health and wellness services in the comfort of their own homes, expanding accessibility and convenience. Complementing this is MaxLab, a diagnostic services arm that extends its reach beyond the company's hospital network. MaxLab utilizes various channels including collaborations with third-party hospitals to provide diagnostic services to a broader patient base.

    The company's business model is built around delivering high-quality healthcare across a spectrum of services and delivery methods. This integrated approach allows Max Healthcare to cater to a wide range of patient needs, from routine check-ups and diagnostics to complex surgical procedures and long-term care. The integration of hospital services, home healthcare, and diagnostic services creates a comprehensive ecosystem that enhances patient care and expands market reach. The company's incorporation in 2001 and continued operation in Gurugram, India demonstrates a long-standing commitment to serving the Indian healthcare market.

    In summary, Max Healthcare Institute Limited’s business centers around providing a wide range of medical services, leveraging an integrated model of hospital care, home healthcare, and diagnostic testing. This multifaceted approach ensures accessibility and comprehensive care across a broad patient population within the Indian healthcare landscape, and positions them as a major player in the country's healthcare industry.

    COMPANY FACTS - MAXHEALTH

    Registered Address

    2nd Floor, Capital Cyberscape,, Sector-59,

    Gurgaon

    HARYANA

    IN

    Tel: 912226101035

    Website:https://www.maxhealthcare.in/

    Investor Relations:http://www.maxhealthcare.in/investors
    Company Details

    Group: Health Care Equipment & Services

    Sector: Health Care

    Industry: Health Care Providers & Services

    Exchange: NATIONAL STOCK EXCHANGE OF INDIA

    Employees: 15,114

    IPO Date: 21/08/2020

    MANAGEMENT - MAXHEALTH

    Mr. Abhay Soi

    Executive Chairman of the Board, Managing Director

    Mr. Yogesh Sareen

    Chief Financial Officer, Senior Director

    Mr. Umesh Gupta

    Chief Human Resources Officer, Senior Director - Human Resources

    Mr. Dhiraj Aroraa

    Senior Vice President - Compliance Officer, Company Secretary

    Mr. D.N. Kumar

    Senior Vice President - Infrastructure

    Mr. Sachin Kumar

    Senior Vice President - Internal Audit

    Mr. Prashant Singh

    Director - Information Technology and Chief Information Officer

    Mr. Anas Wajid

    Senior Director and Chief Sales and Marketing Officer

    Mr. Gagan Palta

    General Counsel, Director

    Mr. Keshav Gupta

    Senior Director - Growth, Mergers and Acquisitions and Business Planning

    Col. Harinder Chehal

    Senior Director and Chief Operating Officer - Cluster Two

    Mr. Mradul Kaushik

    Senior Director - Operations and Planning and Chief Operating Officer (Cluster 1)

    Investor Questions Answered

    Max Healthcare Institute Ltd (MAXHEALTH) Stock FAQs

    Get answers to the most common questions about Max Healthcare Institute Ltd stock price, fundamentals, financial metrics, and investment analysis

    The current share price of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1,083.6. Today, the stock has declined by ₹8.35 (0.76%), trading in a range of ₹1,056.5 to ₹1,088.4. The stock opened at ₹1,056.5 with a trading volume of 34,67,885 shares.
    Max Healthcare Institute Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,04,704.78 crores, P/E ratio of 73.78, ROE of 8.34%, and ROCE of 14.90%. The dividend yield stands at 0.16%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
    The 52-week high price of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1,314.3, while the 52-week low is ₹933.8. Currently trading at ₹1,083.6, the stock is 39.4% away from its 52-week low and 17.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
    Whether to buy Max Healthcare Institute Ltd stock at ₹1,083.6 depends on multiple factors. The stock is currently trading with a P/E ratio of 73.78 and P/B ratio of N/A. Today's performance shows a loss of 0.76%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
    Max Healthcare Institute Ltd offers a dividend yield of 0.16%, which means for every ₹100 invested at the current price of ₹1,083.6, you can expect to receive approximately ₹0.16 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
    Max Healthcare Institute Ltd's key financial metrics include: P/E Ratio: 73.78, P/B Ratio: N/A, ROE: 8.34%, ROCE: 14.90%, Dividend Yield: 0.16%, EPS: ₹14.53, Book Value: ₹96.5, Debt-to-Equity: 0.32, and Current Ratio: N/A. The company's market cap stands at ₹1,04,704.78 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
    Max Healthcare Institute Ltd stock opened at ₹1,056.5 and is currently trading at ₹1,083.6, showing a decline of ₹8.35 (0.76%). The intraday high is ₹1,088.4 and low is ₹1,056.5. The trading volume stands at 34,67,885 shares, indicating strong market participation today.
    Max Healthcare Institute Ltd has a Price-to-Earnings (P/E) ratio of 73.78, which means investors are willing to pay ₹73.78 for every ₹1 of earnings. With an EPS of ₹14.53, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
    Max Healthcare Institute Ltd has a market capitalization of ₹1,04,704.78 crores, making it a large-cap company. Market cap is calculated by multiplying the current stock price (₹1,083.6) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
    Max Healthcare Institute Ltd has a book value of ₹96.5 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,083.6, which is 1022.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
    Max Healthcare Institute Ltd has a Return on Equity (ROE) of 8.34% and Return on Capital Employed (ROCE) of 14.90%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
    Max Healthcare Institute Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
    Max Healthcare Institute Ltd has a debt-to-equity ratio of 0.32, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
    Max Healthcare Institute Ltd has an Earnings Per Share (EPS) of ₹14.53, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,083.6 and P/E ratio of 73.78, investors are paying 73.78 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
    Max Healthcare Institute Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
    Max Healthcare Institute Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
    To analyze Max Healthcare Institute Ltd stock, consider: 1) Fundamental Analysis - Review P/E (73.78), ROE (8.34%), debt-to-equity (0.32), and growth rates. 2) Technical Analysis - Check 52-week range (₹933.80 - ₹1314.30), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1083.60) with book value (₹96.50) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
    The face value (or par value) of Max Healthcare Institute Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,083.6 is 10736x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
    Investing in Max Healthcare Institute Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹933.80 - ₹1314.30). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.32 indicates leverage. 4) Liquidity Risk - Based on trading volume of 34,67,885 shares. 5) Valuation Risk - P/E of 73.78 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
    Max Healthcare Institute Ltd operates in the industry with key metrics: P/E ratio of 73.78, ROE of 8.34%, market cap of ₹1,04,704.78 crores, and dividend yield of 0.16%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.32), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
    Target prices for Max Healthcare Institute Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,083.6, with a 52-week range of ₹933.80 to ₹1314.30. Based on fundamentals like P/E (73.78), ROE (8.34%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
    Consider selling Max Healthcare Institute Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1083.60. 2) Fundamental Deterioration - Declining ROE (currently 8.34%), increasing debt (D/E: 0.32), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
    Tax implications for Max Healthcare Institute Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.16%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.